Reserpine indications and usage: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Doxazosin}} {{CMG}}; {{AE}} {{AK}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = RESERPINE TABLET [EON LABS, INC.] | url = http://d...")
 
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Doxazosin}}
{{Reserpine}}
{{CMG}}; {{AE}} {{AK}}
{{CMG}}; {{AE}} {{AK}}



Revision as of 15:17, 7 March 2014

Reserpine
Reserpine® FDA Package Insert
Indications and Usage
Dosage and Administration
Contraindications
Warnings
Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Reserpine
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]


[1]


References

  1. "RESERPINE TABLET [EON LABS, INC.]". Retrieved 7 March 2014.